NCT04679324View on ClinicalTrials.gov

The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

September 23, 2019

Primary Completion Date

August 10, 2022

Study Completion Date

August 10, 2022

Conditions
Clostridioides Difficile Infection
Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04679324 - The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection | Biotech Hunter | Biotech Hunter